Cargando…
Assessment of estimated glomerular filtration rate based on cystatin C in diabetic nephropathy
INTRODUCTION: GFR is estimated by using creatinine and cystatin C to determine renal dysfunction. Our aim was to evaluate estimated GFR (eGFR) based on cystatin C in type 2 diabetic patients with diabetic nephropathy (DN). METHODS: Study group included 52 controls (46% male, age: 54.5±12.4) and 101...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Nefrologia
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428651/ https://www.ncbi.nlm.nih.gov/pubmed/33599678 http://dx.doi.org/10.1590/2175-8239-JBN-2020-0145 |
_version_ | 1783750418711445504 |
---|---|
author | Akpınar, Kadriye Aslan, Diler Fenkçi, Semin Melahat |
author_facet | Akpınar, Kadriye Aslan, Diler Fenkçi, Semin Melahat |
author_sort | Akpınar, Kadriye |
collection | PubMed |
description | INTRODUCTION: GFR is estimated by using creatinine and cystatin C to determine renal dysfunction. Our aim was to evaluate estimated GFR (eGFR) based on cystatin C in type 2 diabetic patients with diabetic nephropathy (DN). METHODS: Study group included 52 controls (46% male, age: 54.5±12.4) and 101 diabetic patients (46.5% male, age: 58.2±11). The diabetics were divided into three subgroups according to 24-hour urine albumin: normal to mildly increased (A1) (n=51), moderately increased (A2) (n=25), severely increased (A3) (n=25) albuminuria. Creatinine clearance (CrCl) was determined. Correlations between CrCl and eGFRs estimated according to the CKD-EPI, MDRD, and Cockcroft-Gault (CG) formulas, and ROC curves were evaluated. Data were analyzed using SPSS 22.0. RESULTS: Only CKD-EPI-cys eGFR was significantly lower in the A1 group than the controls (p=0.021). All GFRs were lower in the A3 group than the control (CKD-EPI-cr, MDRD, CKD-EPI-cys, CKD-EPI-cr-cys: p=0.0001, CG and CrCl: p=0.001) and A1 (for all GFRs p=0.0001) groups. CKD-EPI-cr (p=0.004), MDRD (p=0.01), CG (p=0.037), CKD-EPI-cys (p=0.033), and CKD-EPI-cr-cys (p=0.016) eGFRs in the A2 group were significantly different from the A1 group. All eGFRs showed a moderate correlation with CrCl in the A1group (CKD-EPI-cr and CKD-EPI-cr-cys: r=0.49, p=0.0001, MDRD: r=0.44, p=0.001, CG r=0.48, p=0.0001: CKD-EPI-cys r=0.40, p=0.004). The area under the CKD-EPI-cys ROC curve was the highest and found to be 0.847 (95%CI 0.763-0.931, p=0.0001). CONCLUSIONS: Our results showed that the CKD-EPI-cys eGFR can be useful in detecting the early stage of DN and more predictive than the others for prediction of DN. |
format | Online Article Text |
id | pubmed-8428651 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Sociedade Brasileira de Nefrologia |
record_format | MEDLINE/PubMed |
spelling | pubmed-84286512021-09-16 Assessment of estimated glomerular filtration rate based on cystatin C in diabetic nephropathy Akpınar, Kadriye Aslan, Diler Fenkçi, Semin Melahat J Bras Nefrol Original Article INTRODUCTION: GFR is estimated by using creatinine and cystatin C to determine renal dysfunction. Our aim was to evaluate estimated GFR (eGFR) based on cystatin C in type 2 diabetic patients with diabetic nephropathy (DN). METHODS: Study group included 52 controls (46% male, age: 54.5±12.4) and 101 diabetic patients (46.5% male, age: 58.2±11). The diabetics were divided into three subgroups according to 24-hour urine albumin: normal to mildly increased (A1) (n=51), moderately increased (A2) (n=25), severely increased (A3) (n=25) albuminuria. Creatinine clearance (CrCl) was determined. Correlations between CrCl and eGFRs estimated according to the CKD-EPI, MDRD, and Cockcroft-Gault (CG) formulas, and ROC curves were evaluated. Data were analyzed using SPSS 22.0. RESULTS: Only CKD-EPI-cys eGFR was significantly lower in the A1 group than the controls (p=0.021). All GFRs were lower in the A3 group than the control (CKD-EPI-cr, MDRD, CKD-EPI-cys, CKD-EPI-cr-cys: p=0.0001, CG and CrCl: p=0.001) and A1 (for all GFRs p=0.0001) groups. CKD-EPI-cr (p=0.004), MDRD (p=0.01), CG (p=0.037), CKD-EPI-cys (p=0.033), and CKD-EPI-cr-cys (p=0.016) eGFRs in the A2 group were significantly different from the A1 group. All eGFRs showed a moderate correlation with CrCl in the A1group (CKD-EPI-cr and CKD-EPI-cr-cys: r=0.49, p=0.0001, MDRD: r=0.44, p=0.001, CG r=0.48, p=0.0001: CKD-EPI-cys r=0.40, p=0.004). The area under the CKD-EPI-cys ROC curve was the highest and found to be 0.847 (95%CI 0.763-0.931, p=0.0001). CONCLUSIONS: Our results showed that the CKD-EPI-cys eGFR can be useful in detecting the early stage of DN and more predictive than the others for prediction of DN. Sociedade Brasileira de Nefrologia 2021-02-12 2021 /pmc/articles/PMC8428651/ /pubmed/33599678 http://dx.doi.org/10.1590/2175-8239-JBN-2020-0145 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Akpınar, Kadriye Aslan, Diler Fenkçi, Semin Melahat Assessment of estimated glomerular filtration rate based on cystatin C in diabetic nephropathy |
title | Assessment of estimated glomerular filtration rate based on cystatin
C in diabetic nephropathy |
title_full | Assessment of estimated glomerular filtration rate based on cystatin
C in diabetic nephropathy |
title_fullStr | Assessment of estimated glomerular filtration rate based on cystatin
C in diabetic nephropathy |
title_full_unstemmed | Assessment of estimated glomerular filtration rate based on cystatin
C in diabetic nephropathy |
title_short | Assessment of estimated glomerular filtration rate based on cystatin
C in diabetic nephropathy |
title_sort | assessment of estimated glomerular filtration rate based on cystatin
c in diabetic nephropathy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428651/ https://www.ncbi.nlm.nih.gov/pubmed/33599678 http://dx.doi.org/10.1590/2175-8239-JBN-2020-0145 |
work_keys_str_mv | AT akpınarkadriye assessmentofestimatedglomerularfiltrationratebasedoncystatincindiabeticnephropathy AT aslandiler assessmentofestimatedglomerularfiltrationratebasedoncystatincindiabeticnephropathy AT fenkciseminmelahat assessmentofestimatedglomerularfiltrationratebasedoncystatincindiabeticnephropathy |